| Literature DB >> 26543890 |
Pujika Emani Munasinghe1, Federica Riu2, Parul Dixit1, Midori Edamatsu1, Pankaj Saxena3, Nathan S J Hamer1, Ivor F Galvin3, Richard W Bunton3, Sharon Lequeux4, Greg Jones5, Regis R Lamberts1, Costanza Emanueli2, Paolo Madeddu2, Rajesh Katare1.
Abstract
This data article contains full list of autophagy related genes that are altered in diabetic heart. This article also shows data from in vitro cultured cardiomyocytes that are exposed the high glucose treatment to simulate hyperglycemic state in vitro. The interpretation of these data and further extensive insights into the regulation of SG biogenesis by AMPK can be found in "Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway" (Munasinghe et al., in press) [1].Entities:
Year: 2015 PMID: 26543890 PMCID: PMC4589802 DOI: 10.1016/j.dib.2015.09.003
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
RT profiler assay showing changes in the expression pattern of autophagy associated genes in the type-2 diabetic mouse heart at 12 weeks of age. Activation of the autophagy genes was evaluated using murine RT-profiler PCR autophagy array (Qiagen, UK). RNA from snap frozen mouse hearts (12 weeks of age) was isolated with TRIzol (Invitrogen, UK). One microgram of total RNA was reverse transcribed and resulting cDNA was amplified in a light cycler (Roche 480, UK). Data were analyzed using the software package from Qiagen and expressed as fold-changes to non-diabetic. Genes showing a fold change of ≥2 and a T-test of <0.05 were considered to be significantly modulated.
Highlighted in green are the significantly modulated autophagy related genes and highlighted in yellow are the significantly modulated cell survival related genes. Genes which are statistically significant (irrespective of the fold changes) are highlighted in red.
Fig. 1A. Representative blots and bar graphs showing the level of Beclin-1 in rat cardiomyocytes exposed to high glucose (30 mM). B. Bar graphs showing Caspase-3/7 activity in normal and high glucose treated cardiomyocytes at different time points. NG – normal glucose; HG – high glucose. Values are mean±SD of 4 independent experiments and are expressed as fold changes to cells treated with NG at corresponding time point. **P<0.01 and ***P<0.001 vs. NG treated cells at corresponding time point.
| Subject area | Cardiovascular |
| More specific subject area | Diabetic heart disease |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |